Inhibikase Therapeutics Advances with FDA Recognition of IkT-001Pro for Pulmonary Arterial Hypertension Treatment
May 9, 2024
Inhibikase Invest Advisor
Five Stocks Ascend to Zacks Rank #1 on January 26: IKT, EGO, MDB, PD, and AVXL
Jan 27, 2024